Back to results

Hemofiltration for Contrast-Induced Nephropathy

Primary Purpose

Chronic Kidney Disease, Cardiac Catheterization

Status

Unknown status

Phase

Not Applicable

Locations

Japan

Study Type

Interventional

Intervention

hemofiltration

About this trial

This is an interventional prevention trial for Chronic Kidney Disease

Eligibility Criteria

20 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Patients with serum creatinine>2.0mg/dl and/or GFR<50ml/min Exclusion Criteria: Emergent cardiac catheterization Patients on chronic dialysis Patients with HYHA>III heart failure

Sites / Locations

First Dept of InternalMedicine, Nara Medical UniversityRecruiting

Outcomes

Primary Outcome Measures

Prevention of contrast-induced acute renal failure, Elevation of serum creatinine

Secondary Outcome Measures

Need for hemodialysis

Full Information

NCT ID

NCT00158080

First Posted

September 7, 2005

Last Updated

September 7, 2005

Sponsor

Nara Medical University

1. Study Identification

Unique Protocol Identification Number

NCT00158080

Brief Title

Hemofiltration for Contrast-Induced Nephropathy

Official Title

Prevention of Contrast-Induced Nephropathy by Real-Time Hemofiltration

Study Type

Interventional

2. Study Status

Record Verification Date

September 2005

Overall Recruitment Status

Unknown status

Study Start Date

undefined (undefined)

Primary Completion Date

undefined (undefined)

Study Completion Date

undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor

Nara Medical University

4. Oversight

5. Study Description

Brief Summary

Contrast-induced acute renal failure can be prevented with hemofiltration which is performed during cardiac catheterization

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study

Chronic Kidney Disease, Cardiac Catheterization

7. Study Design

Primary Purpose

Prevention

Study Phase

Not Applicable

Interventional Study Model

Parallel Assignment

Masking

None (Open Label)

Allocation

Randomized

Enrollment

100 (false)

8. Arms, Groups, and Interventions

Intervention Type

Procedure

Intervention Name(s)

hemofiltration

Primary Outcome Measure Information:

Title

Prevention of contrast-induced acute renal failure, Elevation of serum creatinine

Secondary Outcome Measure Information:

Title

Need for hemodialysis

10. Eligibility

Sex

All

Minimum Age & Unit of Time

20 Years

Maximum Age & Unit of Time

90 Years

Accepts Healthy Volunteers

Eligibility Criteria

Inclusion Criteria: Patients with serum creatinine>2.0mg/dl and/or GFR<50ml/min Exclusion Criteria: Emergent cardiac catheterization Patients on chronic dialysis Patients with HYHA>III heart failure

Central Contact Person:

First Name & Middle Initial & Last Name or Official Title & Degree

Koji Harada, MD

Phone

+81-744-22-3051

Ext

3411

kzharada@naramed-u.ac.jp

Overall Study Officials:

First Name & Middle Initial & Last Name & Degree

Yoshihiko Saito, MD, PhD

Organizational Affiliation

Nara Medical University

Official's Role

Study Director

Facility Information:

Facility Name

First Dept of InternalMedicine, Nara Medical University

City

Kashihara

State/Province

Nara

ZIP/Postal Code

634-8522

Country

Japan

Individual Site Status

Recruiting

Facility Contact:

First Name & Middle Initial & Last Name & Degree

Koji Harada, MD

Phone

+81-744-22-3051

Ext

3411

kzharada@naramed-u.ac.jp

12. IPD Sharing Statement

Citations:

PubMed Identifier

14978842

Citation

Kashyap AS, Anand KP, Kashyap S. Hemofiltration and the prevention of radiocontrast-agent-induced nephropathy. N Engl J Med. 2004 Feb 19;350(8):836-8; author reply 836-8. No abstract available.

Results Reference

background

Learn more about this trial

Hemofiltration for Contrast-Induced Nephropathy

We'll reach out to this number within 24 hrs